Metformin Pharmacokinetics in Mouse Tumors: Implications for Human Therapy

被引：104

作者：

Dowling, Ryan J. O. ^{[1
]}

Lam, Sonya ^{[1
]}

Bassi, Christian ^{[1
,2
]}

Mouaaz, Samar ^{[1
]}

Aman, Ahmed ^{[3
]}

Kiyota, Taira ^{[3
]}

Al-Awar, Rima ^{[3
]}

Goodwin, Pamela J. ^{[4
,5
]}

Stambolic, Vuk ^{[1
,2
]}

机构：

[1] Univ Hlth Network, Princess Margaret Canc Ctr, 101 Coll St, Toronto, ON M5G 1L7, Canada

[2] Univ Toronto, Dept Med Biophys, 101 Coll St, Toronto, ON M5G 1L7, Canada

[3] Ontario Inst Canc Res, Drug Discovery Program, 661 Univ Ave, Toronto, ON M5G 0A3, Canada

[4] Univ Toronto, Mt Sinai Hosp, Dept Med, Div Med Oncol & Hematol, 600 Univ Ave, Toronto, ON M5G 1X5, Canada

[5] Univ Toronto, Princess Margaret Canc Ctr, 600 Univ Ave, Toronto, ON M5G 1X5, Canada

来源：

CELL METABOLISM | 2016年 / 23卷 / 04期

关键词：

BREAST-CANCER;

D O I：

10.1016/j.cmet.2016.03.006

中图分类号：

Q2 [细胞生物学];

学科分类号：

071013 [干细胞生物学];

摘要：

引用

页码：567 / 568

页数：2

共 10 条

[1]

Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice [J].

Anisimov, VN ;

Berstein, LM ;

Egormin, PA ;

Piskunova, TS ;

Popovich, IG ;

Zabezhinski, MA ;

Kovalenko, IG ;

Poroshina, TE ;

Semenchenko, AV ;

Provinciali, M ;

Re, F ;

Franceschi, C .

EXPERIMENTAL GERONTOLOGY, 2005, 40 (8-9) :685-693

[2]

The pharmacogenetics of metformin and its impact on plasma metformin steady-state levels and glycosylated hemoglobin A1c [J].

Christensen, Mette M. H. ;

Brasch-Andersen, Charlotte ;

Green, Henrik ;

Nielsen, Flemming ;

Damkier, Per ;

Beck-Nielsen, Henning ;

Brosen, Kim .

PHARMACOGENETICS AND GENOMICS, 2011, 21 (12) :837-850

[3]

Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus [J].

Cusi, K ;

Consoli, A ;

DeFronzo, RA .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (11) :4059-4067

[4]

Metformin and reduced risk of cancer in diabetic patients [J].

Evans, JMM ;

Donnelly, LA ;

Emslie-Smith, AM ;

Alessi, DR ;

Morris, AD .

BMJ-BRITISH MEDICAL JOURNAL, 2005, 330 (7503) :1304-1305

[5]

Fast liquid chromatographic-tandem mass spectrometric (LC-MS-MS) determination of metformin in plasma samples [J].

Heinig, K ;

Bucheli, F .

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2004, 34 (05) :1005-1011

[6]

Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial [J].

Kordes, Sil ;

Pollak, Michael N. ;

Zwinderman, Aeilko H. ;

Mathot, Ron A. ;

Weterman, Mariette J. ;

Beeker, Aart ;

Punt, Cornelis J. ;

Richel, Dick J. ;

Wilmink, Johanna W. .

LANCET ONCOLOGY, 2015, 16 (07) :839-847

[7]

Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study [J].

Niraula, Saroj ;

Dowling, Ryan J. O. ;

Ennis, Marguerite ;

Chang, Martin C. ;

Done, Susan J. ;

Hood, Nicky ;

Escallon, Jaime ;

Leong, Wey Liang ;

McCready, David R. ;

Reedijk, Michael ;

Stambolic, Vuk ;

Goodwin, Pamela J. .

BREAST CANCER RESEARCH AND TREATMENT, 2012, 135 (03) :821-830

[8]

Inhibition of Lung Tumorigenesis by Metformin Is Associated with Decreased Plasma IGF-I and Diminished Receptor Tyrosine Kinase Signaling [J].

Quinn, Brendan J. ;

Dallos, Matthew ;

Kitagawa, Hiroshi ;

Kunnumakkara, Ajaikumar B. ;

Memmott, Regan M. ;

Hollander, M. Christine ;

Gills, Joell J. ;

Dennis, Phillip A. .

CANCER PREVENTION RESEARCH, 2013, 6 (08) :801-810

[9]

Song RS, 2016, DIABETES CARE, V39, P187, DOI 10.2337/dci15-0013

[10]

Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells [J].

Zakikhani, Mahvash ;

Dowling, Ryan ;

Fantus, I. George ;

Sonenberg, Nahum ;

Pollak, Michael .

CANCER RESEARCH, 2006, 66 (21) :10269-10273

← 1 →